Tectonic Therapeutic, Inc. - TECX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 27, 2026 | SCHEDULE 13G | TCG Crossover GP II, LLC | 3.1% | 584,882 | View |
| Feb 27, 2026 | SCHEDULE 13G | TCG Crossover Fund II, L.P. | 3.1% | 584,882 | View |
| Feb 27, 2026 | SCHEDULE 13G | TCG Crossover GP III, LLC | 3.1% | 584,878 | View |
| Feb 27, 2026 | SCHEDULE 13G | TCG Crossover Fund III, L.P. | 3.1% | 584,878 | View |
| Feb 27, 2026 | SCHEDULE 13G | Chen Yu | 6.2% | 1,169,760 | View |
| Jan 29, 2026 | SCHEDULE 13G | Aberdeen Group plc | 6.1% | 1,141,824 | View |
| Jan 29, 2026 | SCHEDULE 13G | abrdn Inc | 6.1% | 1,141,824 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | EcoR1 Capital, LLC | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Oleg Nodelman | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | EcoR1 Capital Fund Qualified, L.P. | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Deep Track Capital, LP | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Deep Track Biotechnology Master Fund, Ltd. | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | David Kroin | 0.0% | 0 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.